Coverage of Enterococci in Community Acquired Secondary Peritonitis: Results of a Randomized Trial
Introduction: The increasing number of enterococcal infections in hospitals and reports about the development of resistance of these bacteria make it necessary to review their importance as copathogens in secondary peritonitis. Materials and Methods : A prospective randomized controlled trial on pri...
Gespeichert in:
| Veröffentlicht in: | Surgical infections 2000, Vol.1 (2), p.95-107 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 107 |
|---|---|
| container_issue | 2 |
| container_start_page | 95 |
| container_title | Surgical infections |
| container_volume | 1 |
| creator | Röhrborn, A. Wacha, H. Schöffel, U. Billing, A. Aeberhard, P. Gebhard, B. Böcker, I. Schäfer, V. Ohmann, C. |
| description | Introduction:
The increasing number of enterococcal infections in hospitals and reports about the development of resistance of these bacteria make it necessary to review their importance as copathogens
in secondary peritonitis.
Materials and Methods
: A prospective randomized controlled trial on primary therapy of secondary peritonitis was carried out in six centers comparing cephalosporin-based
antibiotic therapy to acylaminopenicillin-based therapy.
Results
: Enterococci were only cultured in 6 of 110 cases from the abdomen and were found in only 5 cases of postoperative complications.
No differences were found between penicillin-based vs. cephalosporin-based therapy.
Conclusion
: The study supports the view that these bacteria continue to play a minor role in secondary peritonitis.
The point has to be emphasized, however, that the patients under study were in relatively good condition (APACHE II median 9 for cephalosporins and 10 for penicillins) and that postoperative cases of peritonitis
were excluded. |
| doi_str_mv | 10.1089/109629600321137 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70537483</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70537483</sourcerecordid><originalsourceid>FETCH-LOGICAL-c254t-eda7548978c4d50c9e7ce8305ad920ec9f3dec759b01376a2160437f2a3c60a3</originalsourceid><addsrcrecordid>eNqFkM9LwzAUx4MoTqdnb5KTt7qkaZLG2xjzBwyUuXtJ01eJtM2WtML8603ZQPDi6T3e9_O-vPdF6IaSe0pyNaNEiVQJQlhKKZMn6IJyLpNcyOw09lFNopxN0GUIn4RQmQpxjiY05SrLlbxA5cJ9gdcfgF2Nl10P3hlnjMW2wwvXtkNn-z2em91gPVT4HYzrKu33-A287V1UbXjAawhD04fRQ-O17irX2u-Ib7zVzRU6q3UT4PpYp2jzuNwsnpPV69PLYr5KTMqzPoFKSz4elZus4sQokAZyRriuVErAqJpVYCRXJYmfCp1SQTIm61QzI4hmU3R3sN16txsg9EVrg4Gm0R24IRSScCaznEVwdgCNdyF4qIutt238qaCkGFMt_qQaN26P1kPZQvXLH2OMAD8A41h3XWOhBN__a_wDY--DAA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70537483</pqid></control><display><type>article</type><title>Coverage of Enterococci in Community Acquired Secondary Peritonitis: Results of a Randomized Trial</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>Röhrborn, A. ; Wacha, H. ; Schöffel, U. ; Billing, A. ; Aeberhard, P. ; Gebhard, B. ; Böcker, I. ; Schäfer, V. ; Ohmann, C.</creator><creatorcontrib>Röhrborn, A. ; Wacha, H. ; Schöffel, U. ; Billing, A. ; Aeberhard, P. ; Gebhard, B. ; Böcker, I. ; Schäfer, V. ; Ohmann, C.</creatorcontrib><description>Introduction:
The increasing number of enterococcal infections in hospitals and reports about the development of resistance of these bacteria make it necessary to review their importance as copathogens
in secondary peritonitis.
Materials and Methods
: A prospective randomized controlled trial on primary therapy of secondary peritonitis was carried out in six centers comparing cephalosporin-based
antibiotic therapy to acylaminopenicillin-based therapy.
Results
: Enterococci were only cultured in 6 of 110 cases from the abdomen and were found in only 5 cases of postoperative complications.
No differences were found between penicillin-based vs. cephalosporin-based therapy.
Conclusion
: The study supports the view that these bacteria continue to play a minor role in secondary peritonitis.
The point has to be emphasized, however, that the patients under study were in relatively good condition (APACHE II median 9 for cephalosporins and 10 for penicillins) and that postoperative cases of peritonitis
were excluded.</description><identifier>ISSN: 1096-2964</identifier><identifier>EISSN: 1557-8674</identifier><identifier>DOI: 10.1089/109629600321137</identifier><identifier>PMID: 12594897</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Adult ; Aged ; Cephalosporins - therapeutic use ; Community-Acquired Infections ; Digestive System Surgical Procedures - methods ; Enterococcus - drug effects ; Enterococcus - pathogenicity ; Female ; Gram-Positive Bacterial Infections - drug therapy ; Gram-Positive Bacterial Infections - surgery ; Humans ; Male ; Middle Aged ; Penicillins - therapeutic use ; Peritonitis - drug therapy ; Peritonitis - surgery ; Postoperative Complications - drug therapy ; Prospective Studies ; Reoperation ; Sepsis - drug therapy ; Sepsis - surgery ; Surgical Wound Infection - drug therapy</subject><ispartof>Surgical infections, 2000, Vol.1 (2), p.95-107</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c254t-eda7548978c4d50c9e7ce8305ad920ec9f3dec759b01376a2160437f2a3c60a3</citedby><cites>FETCH-LOGICAL-c254t-eda7548978c4d50c9e7ce8305ad920ec9f3dec759b01376a2160437f2a3c60a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.liebertpub.com/doi/epdf/10.1089/109629600321137$$EPDF$$P50$$Gmaryannliebert$$H</linktopdf><linktohtml>$$Uhttps://www.liebertpub.com/doi/full/10.1089/109629600321137$$EHTML$$P50$$Gmaryannliebert$$H</linktohtml><link.rule.ids>314,780,784,3042,4024,21723,27923,27924,27925,55291,55303</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12594897$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Röhrborn, A.</creatorcontrib><creatorcontrib>Wacha, H.</creatorcontrib><creatorcontrib>Schöffel, U.</creatorcontrib><creatorcontrib>Billing, A.</creatorcontrib><creatorcontrib>Aeberhard, P.</creatorcontrib><creatorcontrib>Gebhard, B.</creatorcontrib><creatorcontrib>Böcker, I.</creatorcontrib><creatorcontrib>Schäfer, V.</creatorcontrib><creatorcontrib>Ohmann, C.</creatorcontrib><title>Coverage of Enterococci in Community Acquired Secondary Peritonitis: Results of a Randomized Trial</title><title>Surgical infections</title><addtitle>Surg Infect (Larchmt)</addtitle><description>Introduction:
The increasing number of enterococcal infections in hospitals and reports about the development of resistance of these bacteria make it necessary to review their importance as copathogens
in secondary peritonitis.
Materials and Methods
: A prospective randomized controlled trial on primary therapy of secondary peritonitis was carried out in six centers comparing cephalosporin-based
antibiotic therapy to acylaminopenicillin-based therapy.
Results
: Enterococci were only cultured in 6 of 110 cases from the abdomen and were found in only 5 cases of postoperative complications.
No differences were found between penicillin-based vs. cephalosporin-based therapy.
Conclusion
: The study supports the view that these bacteria continue to play a minor role in secondary peritonitis.
The point has to be emphasized, however, that the patients under study were in relatively good condition (APACHE II median 9 for cephalosporins and 10 for penicillins) and that postoperative cases of peritonitis
were excluded.</description><subject>Adult</subject><subject>Aged</subject><subject>Cephalosporins - therapeutic use</subject><subject>Community-Acquired Infections</subject><subject>Digestive System Surgical Procedures - methods</subject><subject>Enterococcus - drug effects</subject><subject>Enterococcus - pathogenicity</subject><subject>Female</subject><subject>Gram-Positive Bacterial Infections - drug therapy</subject><subject>Gram-Positive Bacterial Infections - surgery</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Penicillins - therapeutic use</subject><subject>Peritonitis - drug therapy</subject><subject>Peritonitis - surgery</subject><subject>Postoperative Complications - drug therapy</subject><subject>Prospective Studies</subject><subject>Reoperation</subject><subject>Sepsis - drug therapy</subject><subject>Sepsis - surgery</subject><subject>Surgical Wound Infection - drug therapy</subject><issn>1096-2964</issn><issn>1557-8674</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM9LwzAUx4MoTqdnb5KTt7qkaZLG2xjzBwyUuXtJ01eJtM2WtML8603ZQPDi6T3e9_O-vPdF6IaSe0pyNaNEiVQJQlhKKZMn6IJyLpNcyOw09lFNopxN0GUIn4RQmQpxjiY05SrLlbxA5cJ9gdcfgF2Nl10P3hlnjMW2wwvXtkNn-z2em91gPVT4HYzrKu33-A287V1UbXjAawhD04fRQ-O17irX2u-Ib7zVzRU6q3UT4PpYp2jzuNwsnpPV69PLYr5KTMqzPoFKSz4elZus4sQokAZyRriuVErAqJpVYCRXJYmfCp1SQTIm61QzI4hmU3R3sN16txsg9EVrg4Gm0R24IRSScCaznEVwdgCNdyF4qIutt238qaCkGFMt_qQaN26P1kPZQvXLH2OMAD8A41h3XWOhBN__a_wDY--DAA</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>Röhrborn, A.</creator><creator>Wacha, H.</creator><creator>Schöffel, U.</creator><creator>Billing, A.</creator><creator>Aeberhard, P.</creator><creator>Gebhard, B.</creator><creator>Böcker, I.</creator><creator>Schäfer, V.</creator><creator>Ohmann, C.</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2000</creationdate><title>Coverage of Enterococci in Community Acquired Secondary Peritonitis: Results of a Randomized Trial</title><author>Röhrborn, A. ; Wacha, H. ; Schöffel, U. ; Billing, A. ; Aeberhard, P. ; Gebhard, B. ; Böcker, I. ; Schäfer, V. ; Ohmann, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c254t-eda7548978c4d50c9e7ce8305ad920ec9f3dec759b01376a2160437f2a3c60a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Cephalosporins - therapeutic use</topic><topic>Community-Acquired Infections</topic><topic>Digestive System Surgical Procedures - methods</topic><topic>Enterococcus - drug effects</topic><topic>Enterococcus - pathogenicity</topic><topic>Female</topic><topic>Gram-Positive Bacterial Infections - drug therapy</topic><topic>Gram-Positive Bacterial Infections - surgery</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Penicillins - therapeutic use</topic><topic>Peritonitis - drug therapy</topic><topic>Peritonitis - surgery</topic><topic>Postoperative Complications - drug therapy</topic><topic>Prospective Studies</topic><topic>Reoperation</topic><topic>Sepsis - drug therapy</topic><topic>Sepsis - surgery</topic><topic>Surgical Wound Infection - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Röhrborn, A.</creatorcontrib><creatorcontrib>Wacha, H.</creatorcontrib><creatorcontrib>Schöffel, U.</creatorcontrib><creatorcontrib>Billing, A.</creatorcontrib><creatorcontrib>Aeberhard, P.</creatorcontrib><creatorcontrib>Gebhard, B.</creatorcontrib><creatorcontrib>Böcker, I.</creatorcontrib><creatorcontrib>Schäfer, V.</creatorcontrib><creatorcontrib>Ohmann, C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgical infections</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Röhrborn, A.</au><au>Wacha, H.</au><au>Schöffel, U.</au><au>Billing, A.</au><au>Aeberhard, P.</au><au>Gebhard, B.</au><au>Böcker, I.</au><au>Schäfer, V.</au><au>Ohmann, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coverage of Enterococci in Community Acquired Secondary Peritonitis: Results of a Randomized Trial</atitle><jtitle>Surgical infections</jtitle><addtitle>Surg Infect (Larchmt)</addtitle><date>2000</date><risdate>2000</risdate><volume>1</volume><issue>2</issue><spage>95</spage><epage>107</epage><pages>95-107</pages><issn>1096-2964</issn><eissn>1557-8674</eissn><abstract>Introduction:
The increasing number of enterococcal infections in hospitals and reports about the development of resistance of these bacteria make it necessary to review their importance as copathogens
in secondary peritonitis.
Materials and Methods
: A prospective randomized controlled trial on primary therapy of secondary peritonitis was carried out in six centers comparing cephalosporin-based
antibiotic therapy to acylaminopenicillin-based therapy.
Results
: Enterococci were only cultured in 6 of 110 cases from the abdomen and were found in only 5 cases of postoperative complications.
No differences were found between penicillin-based vs. cephalosporin-based therapy.
Conclusion
: The study supports the view that these bacteria continue to play a minor role in secondary peritonitis.
The point has to be emphasized, however, that the patients under study were in relatively good condition (APACHE II median 9 for cephalosporins and 10 for penicillins) and that postoperative cases of peritonitis
were excluded.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>12594897</pmid><doi>10.1089/109629600321137</doi><tpages>13</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1096-2964 |
| ispartof | Surgical infections, 2000, Vol.1 (2), p.95-107 |
| issn | 1096-2964 1557-8674 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70537483 |
| source | Mary Ann Liebert Online Subscription; MEDLINE |
| subjects | Adult Aged Cephalosporins - therapeutic use Community-Acquired Infections Digestive System Surgical Procedures - methods Enterococcus - drug effects Enterococcus - pathogenicity Female Gram-Positive Bacterial Infections - drug therapy Gram-Positive Bacterial Infections - surgery Humans Male Middle Aged Penicillins - therapeutic use Peritonitis - drug therapy Peritonitis - surgery Postoperative Complications - drug therapy Prospective Studies Reoperation Sepsis - drug therapy Sepsis - surgery Surgical Wound Infection - drug therapy |
| title | Coverage of Enterococci in Community Acquired Secondary Peritonitis: Results of a Randomized Trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T12%3A14%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coverage%20of%20Enterococci%20in%20Community%20Acquired%20Secondary%20Peritonitis:%20Results%20of%20a%20Randomized%20Trial&rft.jtitle=Surgical%20infections&rft.au=R%C3%B6hrborn,%20A.&rft.date=2000&rft.volume=1&rft.issue=2&rft.spage=95&rft.epage=107&rft.pages=95-107&rft.issn=1096-2964&rft.eissn=1557-8674&rft_id=info:doi/10.1089/109629600321137&rft_dat=%3Cproquest_cross%3E70537483%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70537483&rft_id=info:pmid/12594897&rfr_iscdi=true |